More stories

  • in

    The case for buying bonds right now

    Investors may want to consider bonds to help navigate the market’s recent volatility.
    Joanna Gallegos, BondBloxx co-founder and CEO, recommends prioritizing income and high-yield bonds.

    “It can be really important to start looking at fixed income as you start to diversify and manage more risk,” she told CNBC’s “ETF Edge” on Monday.
    Gallegos also suggests moving out on the yield curve.
    “Fixed income is very different today than it was two years ago,” she said. “We’re at the end of the great rate hike. So, rates are high, and that makes a lot of difference in a portfolio today than it did when we started out with rates being almost at zero.” 

    Arrows pointing outwards

    PIMCO’s Jerome Schneider, who manages one of the biggest actively managed bond exchange-traded funds in the world, also advises investors to look toward bonds.
    “They’re entering these market conditions with a generally underweight posture to fixed income,” the firm’s head of short-term portfolio management said. “What we’re seeing here is that there are better risk-adjusted returns by being an actively managed, fixed income diversified portfolio than there have been in many years.”

    Schneider predicts the Federal Reserve will start cutting rates this year and warns money market funds will likely see yields ebb “pretty quickly.”
    “Favoring the front part of the yield curve is a place that we think is … most attractive at this point in time,” Schneider said. “In the 2-, 3-, [and] 5-year spaces, there’s plenty of opportunities across diversified portfolios to look.”

    Don’t miss these insights from CNBC PRO

    Disclaimer More

  • in

    Rivian tops Wall Street’s second-quarter expectations amid cost cuts

    Rivian Automotive beat Wall Street’s top- and bottom-line expectations for the second quarter.
    The electric vehicle maker, which is still losing thousands of dollars for every vehicle it makes, has been focused on reducing costs.

    Workers assemble second-generation R1 vehicles at electric auto maker Rivian’s manufacturing facility in Normal, Illinois, U.S. June 21, 2024. 
    Joel Angel Juarez | Reuters

    Rivian Automotive beat Wall Street’s top- and bottom-line expectations for the second quarter as the electric vehicle maker continues to take costs out of its business.
    Here is how the company did, compared to estimates from analysts polled by LSEG:

    Earnings per share: Loss of $1.13 adjusted vs. loss of $1.21 expected
    Automotive revenue: $1.16 billion vs. $1.14 billion expected

    The company’s net losses widened during the second quarter to $1.46 billion, or a loss of $1.46 per share, compared with a year earlier of $1.2 billion, or a loss of $1.27 per share.
    Its adjusted earnings before interest, taxes, depreciation and amortization, or EBITDA was about level from the same period as a year ago at a loss of $860 million.
    Rivian on Tuesday reaffirmed its 2024 guidance of 57,000 total units of production, a loss of $2.7 billion in adjusted EBITDA and $1.2 billion in capital expenditures. It also said it remains on track for a positive gross profit during the fourth quarter.
    Through the first six months of the year Rivian produced about 23,600 vehicles, including only 9,162 during the second quarter due to downtime at the company’s plant to retool and reduce costs.
    Rivian said a majority of the vehicles sold during the second quarter were from inventory prior to the production cost cuts, meaning most efficiency gains were not realized during that time.

    The second-quarter results come more than a month after Rivian held an investor day that focused on cost-cutting efforts, efficiency gains and in-house technologies and software. The event came days after Rivian announced plans for Volkswagen to invest up to $5 billion in the EV startup, starting with an initial investment of $1 billion.
    Shares of Rivian are off 37% this year amid slower-than-expected demand for EVs as well as Rivian’s significant cash burn. The stock closed Tuesday at $14.80, up 1.3%.
    Rivian, which is still losing thousands of dollars for every vehicle it makes, has been focused on reducing costs. Rivian CEO RJ Scaringe said in June that efficiencies earlier this year in products and manufacturing are expected to lead to 20% material cost reductions in its current vehicles, followed by 45% targeted reductions in its upcoming “R2” vehicles, which are projected to begin production in early 2026.
    Rivian’s expenditures through the first half of the year were $537 million, including $283 million during the second quarter.
    Rivian ended the second quarter with $9.18 billion in total liquidity, including $7.87 billion in cash, cash equivalents and short-term investments.
    Correction: Rivian’s net loss during the second quarter was $1.46 billion. This amount was incorrectly stated in a previous version of the article. More

  • in

    Federal safety hearing over 737 Max blowout puts Boeing, Spirit AeroSystems factories in spotlight

    Boeing and its fuselage supplier Spirit AeroSystems are facing a two-day safety hearing that started Tuesday.
    The NTSB released more than 3,000 pages of documents, including transcripts of interviews with Boeing and Spirit AeroSystems employees, as well as from pilots, flight attendants and executives.
    A Boeing safety executive said the company is working on a design change to avoid a repeat of the midair blowout.

    Jennifer Homendy, Chair of the National Transportation Safety Board, speaks during investigative hearing, into the blowout of a left mid exit door plug on a Boeing 737-9 MAX during Alaska Airlines Flight 1282 flight on January 5, 2024, at the National Transportation Safety Board headquarters in Washington D.C. United States on August 6, 2024. (Photo by Bryan Olin Dozier/Anadolu via Getty Images)
    Bryan Olin Dozier | Anadolu | Getty Images

    A Boeing safety executive told a federal safety hearing on Tuesday that the company is working on design changes to avoid a repeat of the near catastrophic blowout of a door plug from a practically new 737 Max 9 at the start of the year.
    The National Transportation Safety Board — the body in charge of aviation accident investigations in the U.S. — released more than 3,000 pages of documents ahead its full two-day hearing about Flight 1282, including interviews with employees at Boeing and its beleaguered fuselage maker Spirit AeroSystems, some of which pointed to rework.

    “I just want a word of caution here, this is not a PR campaign for Boeing,” NTSB Chair Jennifer Homendy said. “This is an investigation on what happened on Jan. 5. Understand?”
    Bolts that were meant to hold the door in place weren’t attached, according to preliminary investigation results. While there were no serious injuries, the accident put the spotlight back on Boeing’s safety procedures and a series of manufacturing flaws that required changes at the company’s factories, including what led up to the door plug getting removed, but not secured last year.
    “They are working on some design changes that will allow the door, the plug, to not be closed if there is any issue, until it is firmly secure,” said Elizabeth Lund, who heads safety for Boeing’s commercial airplane unit. The changes would be implemented within the year, Lund said.

    An exhibit displayed during an investigative hearing by the National Transportation Safety Board (NTSB) in Washington, DC, US, on Tuesday, Aug. 6, 2024. 
    Al Drago | Bloomberg | Getty Images

    The blowout plunged Boeing back into crisis mode and prompted a management shakeup, including the appointment of a new CEO, Robert “Kelly” Ortberg, an aerospace veteran who previously headed Rockwell Collins. He starts on Thursday.
    The accident has also delayed deliveries of new planes to customers, further eroding the iconic U.S. manufacturer’s relationship with airlines — and with regulators.

    Outgoing CEO Dave Calhoun has said Boeing is working to stamp out so-called traveled work, where defective components of the plane need to be fixed, out of sequence, before the aircraft are handed over to customers. Boeing is in the process of buying back Spirit AeroSystems, a move the company says will give it a closer eye on quality.
    “We’ve been put in uncharted waters to where … we were replacing doors like we were replacing our underwear, forward doors, cargo doors, E/E bay doors,” said one Boeing worker, whose name was redacted from testimony. “The planes come in jacked up every day.”

    Read more CNBC airline news More

  • in

    Arsenal names Athletic Brewing as official nonalcoholic beer partner

    Athletic Brewing Company is teaming up with Arsenal, becoming the English soccer team’s first nonalcoholic beer partner.
    Arsenal will feature Athletic Brewing’s Run Wild IPA at Emirates Stadium for both men’s and women’s matches, and Athletic Brewing will launch a marketing campaign and a series of promotions in return.
    Sales of no- and low-alcoholic beer are rising in the U.K., surging 38% on match days this summer.

    Athletic Brewing Company is the official nonalcoholic beer partner of Arsenal F.C.
    Courtesy: Athletic Brewing Co.

    Athletic Brewing Company has scored a partnership with Arsenal, becoming the English soccer team’s first official nonalcoholic beer partner.
    Arsenal will feature Athletic Brewing’s Run Wild IPA at Emirates Stadium for both men’s and women’s matches, and Athletic Brewing will launch a marketing campaign and a series of promotions in return, according to a press release.

    Run Wild IPA is less than 0.5% alcohol by volume, or ABV.
    The deal represents an opportunity for America’s largest nonalcoholic brewery to expand in the U.K.

    Athletic Brewing Company is the official nonalcoholic beer partner of Arsenal F.C.
    Courtesy: Athletic Brewing Co.

    “Our international footprint is expanding, and alcohol moderation is sweeping the globe, specifically among the next generation of consumers,” Bill Shufelt, co-founder and CEO of Athletic, said in the release. “This partnership represents an exciting milestone in our journey to revolutionize the way the world drinks.”
    Sales of no- and low-alcoholic beer are rising in the U.K., surging 38% on match days this summer, and there are similar trends in the U.S. with off-premise sales of nonalcoholic beer up nearly 30% year to date, according to the release.
    Arsenal is the latest sports entity to embrace nonalcoholic beer. Guinness 0.0 is the official nonalcoholic beer partner of the Premier League, and Formula 1 promotes Heineken 0.0.
    “New partners like Athletic are vital in supporting our growth so we can continue to invest in our teams and compete for major trophies,” Arsenal’s Chief Commercial Officer Juliet Slot said in the release.

    Don’t miss these insights from CNBC PRO More

  • in

    Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

    President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023.
    Chris Kleponis | Bloomberg | Getty Images

    Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
    Good afternoon! The first round of Medicare drug price negotiations has come to an end – but we still don’t know the final prices that the U.S. government and pharmaceutical companies have agreed on. 

    Medicare will disclose the new negotiated prices for 10 drugs at the beginning of September. Those prices will then go into effect in 2026. 
    Still, drugmakers appear to be less concerned about the impact of those new negotiated prices on their businesses than in recent months, at least in the short term. They all maintain that Medicare drug price negotiations are a long-term threat to the pharmaceutical industry’s drug innovation and profits, but the immediate dust has somewhat settled. 
    That’s based on executive commentary during the recent quarterly earnings calls of Bristol Myers Squibb and Johnson & Johnson, among other companies. 
    President Joe Biden’s Inflation Reduction Act gave Medicare the power to directly hash out drug prices with manufacturers for the first time in the federal program’s nearly 60-year history. The process aims to make expensive medications more affordable for older Americans. 
    On July 26, Bristol Myers Squibb CEO Christopher Boerner confirmed that the company received the government’s final price for its blood thinner Eliquis, which it shares with Pfizer. 

    He said now that the company has seen that price, it is “increasingly confident in our ability to navigate the impact” of Medicare drug price negotiations on the treatment. Bristol Myers will provide more details about the expected impact on its investor relations website once Medicare publicly discloses the final prices, according to Boerner. 
    Meanwhile, AbbVie CEO Robert Michael said a day earlier that the drugmaker has included the expected sales hit to its top-selling leukemia drug, Imbruvica, in its financial forecasts. 
    “We’ve come out and said that even with modeling that impact in, that we still expect to deliver on our long-term outlook,” Michael said on the company’s earnings call. 
    On July 17, J&J Worldwide Chairman Jennifer Taubert similarly said the company’s long-term growth outlook “still looks very good to us today” after seeing the negotiated prices for its blood thinner Xarelto and psoriasis treatment Stelara. 
    Novartis CEO Vasant Narasimhan said on July 18 that the short-term impact from Medicare drug price negotiations “might be manageable on our first set of drugs.” The company’s heart failure drug, Entresto, is among those selected for negotiations. 
    But Narasimhan said the policy in the long-term is “really not good for innovation [or] good for patients” in the U.S.
    “I think it’s very important to say the policy is not a good one. It’s bad for American patients, it’s bad for innovation and [I] sincerely hope that it gets corrected,” he said. 
    Executives at each of the drugmakers similarly emphasized their opposition to Medicare drug price negotiations on their respective earnings calls. 
    “We continue to believe that arbitrary price setting by the government on life-saving medicines is not good public policy,” Bristol Myers Squibb’s Boerner said on the company’s earnings call. “Irrespective of short-term dynamics, we remain very concerned about the long-term implications of IRA on innovation.”
    Lawsuits brought by Merck and Novartis against the negotiations are awaiting decisions from district courts. Each case brings claims that overlap with suits from Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, J&J and industry trade groups that have been rejected in recent months. 
    Feel free to send any tips, suggestions, story ideas and data to Annika at [email protected].

    Latest in health-care technology

    Health care goes Hollywood (sort of)
    Lights, camera, action!
    If you’re like me, health care is probably not the first thing you associate with the entertainment industry. Unless, of course, we’re talking about the hit medical drama “Grey’s Anatomy.” 
    But Northwell Health, the largest health system in the state of New York, is breaking new ground in the entertainment world. In late July, it launched a TV and film production studio called Northwell Studios. 
    The goal is not to turn the studio into a money-making machine, said Ramon Soto, chief marketing officer at Northwell Health. The health system actually plans to ensure most projects remain cost neutral. 
    Instead, Soto said the studio was created to help raise awareness about Northwell, especially since it operates within a competitive and saturated market. The New York metropolitan area is teeming with prestigious health systems and academic medical centers, and it’s Soto’s job to cut through the noise. 
    Northwell has dabbled with entertainment projects in the past. It participated in the Netflix docu-drama series “Lenox Hill” as well as an Academy Award-shortlisted Covid-19 documentary and a documentary about mental health with HBO. 
    Soto said Northwell Studios is meant to help the health system carry out these kinds of projects more regularly. 
    “The intention behind Northwell Studios is not, ‘Hey, we’re going to show up, it’s showbiz and get our name in lights.’ It’s really to create a bit more of an infrastructure to do this on a regular basis,” Soto told CNBC in an interview. “I’m not building a soundstage, I’m not building a studio, but I have millions of square feet and 21 hospitals and 88,000 employees, caregivers, storytellers.”
    Soto said there are already five projects in development, though not all of them will necessarily come to completion. He said unscripted content has been Northwell’s “bread and butter” so far, and there’s an extensive consent process in place for the patients and employees who opt in. 
    Northwell Studios is also exploring opportunities to produce scripted content, but patients shouldn’t expect to see actors and camera crews running through the halls.
    “We’re a health system, we can’t disrupt our operations or patient flows,” Soto said. “We’ll figure out the least disruptive, most impactful way to capture this content.”
    Feel free to send any tips, suggestions, story ideas and data to Ashley at [email protected]. More

  • in

    Markets are counting on the Fed to head off recession with sizeable interest rate cuts

    In the market’s eyes, the Fed finds itself either poised to head off recession or doomed to repeat the mistakes of its recent past.
    “No recession today, but one is increasingly inevitable by year-end if the Fed fails to act,” said Steve Blitz, chief U.S. economist at TS Lombard.
    Traders are pricing in a half-point September cut, followed by aggressive easing that could lop 2.25 percentage points off the Fed’s short-term borrowing rate by the end of next year.

    Federal Reserve Chairman Jerome Powell takes a question from a reporter during a news conference following a Federal Open Market Committee meeting at the William McChesney Martin Jr. Federal Reserve Board Building on July 31, 2024 in Washington, DC. 
    Andrew Harnik | Getty Images

    In the market’s eyes, the Federal Reserve finds itself either poised to head off a recession or doomed to repeat the mistakes of its recent past — when it was too late seeing a coming storm.
    How Chair Jerome Powell and his cohorts at the central bank react likely will go a long way in determining how investors negotiate such a turbulent climate. Wall Street has been on a wild ride the past several days, with a relief rally Tuesday ameliorating some of the damage since recession fears intensified last week.

    “In sum, no recession today, but one is increasingly inevitable by year-end if the Fed fails to act,” Steven Blitz, chief U.S. economist at TS Lombard, said in a note to clients. “But they will, beginning with a [half percentage point] cut in September telegraphed in late August.”
    Blitz’s comments represent the widespread sentiment on Wall Street — little feeling that a recession is an inevitability unless, of course, the Fed fails to act. Then the probability ramps up.
    Disappointing economic data recently generated worries that the Fed missed an opportunity at its meeting last week to, if not cut rates outright, send a clearer signal that easing is on the way. It helped conjure up memories of the not-too-distant past when Fed officials dismissed the 2021 inflation surge as “transitory” and were pressed into what ultimately was a series of harsh rate hikes.
    Now, with a weak jobs report from July in hand and worries intensifying over a downturn, the investing community wants the Fed to take strong action before it misses the chance.
    Traders are pricing in a strong likelihood of that half-point September cut, followed by aggressive easing that could lop 2.25 percentage points off the Fed’s short-term borrowing rate by the end of next year, as judged by 30-day fed funds futures contracts. The Fed currently targets its key rate between 5.25%-5.5%.

    “The unfortunate reality is that a range of data confirm what the rise in the unemployment rate is now prominently signaling — the US economy is at best at risk of falling into a recession and at worst already has,” Citigroup economist Andrew Hollenhorst wrote. “Data over the next month is likely to confirm the continued slowdown, keeping a [half-point] cut in September likely and a potential intermeeting cut on the table.”

    Emergency cut unlikely

    With the economy still creating jobs and stock market averages near record highs, despite the recent sell-off, an emergency cut between now and the Sept. 17-18 open market committee seems a longshot to say the least.
    The fact that it’s even being talked about, though, indicates the depth of recession fears. In the past, the Fed has implemented just nine such cuts, and all have come amid extreme duress, according to Bank of America.
    “If the question is, ‘should the Fed consider an intermeeting cut now?’, we think history says, ‘no, not even close,'” said BofA economist Michael Gapen.
    Lacking a catalyst for an intermeeting cut, the Fed is nonetheless expected to cut rates almost as swiftly as it hiked from March 2022-July 2023. It could start the process later this month, when Powell delivers his expected keynote policy speech during the Fed’s annual retreat in Jackson Hole, Wyoming. Powell is already being expected to signal how the easing path will unfold.
    Joseph LaVorgna, chief U.S. economist at SMBC Nikko Securities, expects the Fed to cut rates 3 full percentage points by the end of 2025, more aggressive than the current market outlook.
    “Go big or go home. The Fed has clearly said that rates are too high. Why would they be slow at removing the tightness?” he said. “They’ll be quick in cutting if for no other reason than rates aren’t at the right level. Why wait?”
    LaVorgna, though, isn’t convinced the Fed is in a life-or-death battle against recession. However, he noted that “normalizing” the inverted yield curve, or getting longer-dated securities back to yielding more than their shorter-dated counterparts, will be an integral factor in avoiding an economic contraction.
    Over the weekend, Goldman Sachs drew some attention to when it raised its recession forecast, but only to 25% from 15%. That said, the bank did note that one reason it does not believe a recession is imminent is that the Fed has plenty of room to cut — 5.25 percentage points if necessary, not to mention the capacity to restart its bond-buying program known as quantitative easing.
    Still, any quakes in the data, such as Friday’s downside surprise to the nonfarm payrolls numbers, could ignite recession talk quickly.
    “The Fed is as behind the economic curve now as it was behind the inflation curve back in 2021-2022,” economist and strategist David Rosenberg, founder of Rosenberg Research, wrote Tuesday. He added that the heightened expectation for cuts “smacks of a true recession scenario because the Fed has rarely done this absent an official economic downturn — heading into one, already in one, or limping out of one.” More

  • in

    Disney raises streaming prices for Hulu, Disney+ and ESPN+

    Starting mid-October, most plans for Disney+, Hulu and ESPN+ will cost $1 to $2 more per month.
    The price hikes come as Disney continues to push its customers toward bundles to get a bigger bang for their buck.

    The atmosphere at the Disney Bundle Celebrating National Streaming Day at The Row in Los Angeles on May 19, 2022.
    Presley Ann | Getty Images Entertainment | Getty Images

    Disney is raising prices on its streaming platforms.
    Starting mid-October, most plans for Disney+, Hulu and ESPN+ will cost $1 to $2 more per month, according to a press release Tuesday. The most expensive plans for Hulu, which include live TV, will cost $6 more per month.

    Disney+ basic and premium will be priced at $9.99 and $15.99, respectively. Hulu with ads will cost $9.99 monthly, while Hulu without adds will cost $18.99 per month. ESPN+, which features ads, will cost $11.99 per month.
    The price hikes come as Disney continues to push its customers toward bundles to get a bigger bang for their buck.
    For some time, Disney has offered a bundle of its own services, either Hulu and Disney+, or the two streaming services plus ESPN+. The existing bundle of Disney+ and Hulu, with ads, will also get a price hike this fall, up $1 to $10.99 per month. The same bundle without ads won’t see any price increase from the current rate of $19.99 per month.
    Disney has also partnered with Warner Bros. Discovery to offer a bundle, which will include Disney+, Hulu and Max. In July, the companies announced the bundle would be available for $16.99 with ads, and $29.99 commercial free, noting “a savings of 38% compared with the price of the services purchased separately.”
    Disney also aims to entice subscribers with ABC News Live and a playlist featuring preschool content, available to all subscribers starting Sept. 4, according to the release Tuesday. The company plans to introduce four more curated playlists for premium subscribers.

    “Playlists are the latest example of how we’re providing the best value and experience for our subscribers every time they open Disney+,” Alisa Bowen, president of the streaming platform, said in the news release.
    Disney reports its fiscal third-quarter earnings before the bell on Wednesday.

    Don’t miss these insights from CNBC PRO More

  • in

    The stockmarket rout may not be over

    For a while on August 5th things were looking awful. During the Asian trading session Japan’s benchmark Topix share index had fallen by 12%, marking its worst day since 1987. Stock prices in South Korea and Taiwan had tanked by 9% and 8% respectively, and European markets were falling. Before trading began in America, the VIX index, which measures how wildly traders expect share prices to swing, was at a level it had only reached early in the covid-19 pandemic and after Lehman Brothers collapsed in 2008. Ominously, though gold is usually a hedge against chaos, its price was falling—suggesting that investors might be selling assets they would rather hold on to in order to stay afloat. The previous week’s rout in global markets seemed to be spiralling into a full-blown crisis. More